Use of statins after liver transplantation is associated with improved survival: results of a nationwide study
ContributorsBecchetti, Chiara
; Dirchwolf, Melisa
; Schropp, Jonas
; Magini, Giulia; Müllhaupt, Beat; Immer, Franz; Dufour, Jean-François; Banz, Vanessa; Berzigotti, Annalisa
; Bosch, Jaume; Swiss Transplant Cohort Study
Published inAlimentary pharmacology & therapeutics, vol. 56, no. 7, p. 1194-1204
Publication date2022-10
First online date2022-08-18
Abstract
Keywords
- Cardiovascular disease
- Dyslipidemia
- Solid organ transplantation
- Survival
- Adult
- Aged
- Graft Survival
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
- Liver Transplantation
- Male
- Middle Aged
- Retrospective Studies
- Risk Factors
- Treatment Outcome
Affiliation entities
- Faculté de médecine / Section de médecine clinique / Département de médecine
- Faculté de médecine / Section de médecine clinique / Département de chirurgie
- Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale
- Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique
Citation (ISO format)
BECCHETTI, Chiara et al. Use of statins after liver transplantation is associated with improved survival: results of a nationwide study. In: Alimentary pharmacology & therapeutics, 2022, vol. 56, n° 7, p. 1194–1204. doi: 10.1111/apt.17192
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
- PID : unige:168968
- DOI : 10.1111/apt.17192
- PMID : 35979872
- PMCID : PMC9545989
Additional URL for this publicationhttps://onlinelibrary.wiley.com/doi/10.1111/apt.17192
Journal ISSN0269-2813